BridgeMD
FAPI-PET imaging in solid tumors
EU CTIS ID: 2024-514967-25-00
What this study is testing
To improve non-invasive diagnostics of malignancy in tumors of pancreas, stomach, and bile ducts, as well as in epithelial ovarian cancer (EOC)
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- 1. The subject has given written consent to participate in the study
- 2. The subject has suspected pancreatic, gastric, biliary or epithelial ovarian cancer based on multimodal strategy including markers in blood, markers in tissue and imaging diagnostics; scheduled for surgical removal of this lesion with histopathological confirmation of diagnosis.
You likely can't join if
- Age ≤18 year
- Pregnancy and lactation
- Known metastatic disease (Not applicable for the EOC study group as most cases are already metastasized at the point of primary diagnosis)
- Significantly reduced renal function
- Allergy to iodinated contrast media
- Subjects that for some reason are unable to exercise their own rights, such as cognitive function impairment
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.